Sarepta Therapeutics, Inc. (BMV:SRPT)
Mexico
· Delayed Price · Currency is MXN 361.00
0.00 (0.00%)
At close: Mar 6, 2026
Sarepta Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -713.41 | 235.24 | -535.98 | -703.49 | -418.78 | Upgrade
|
| Depreciation & Amortization | 44.52 | 37.72 | 44.4 | 41.86 | 38.02 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | -102 | - | -102 | Upgrade
|
| Loss (Gain) From Sale of Investments | 12 | -40.28 | -15.86 | -8.08 | 4.39 | Upgrade
|
| Stock-Based Compensation | 123.4 | 184.3 | 182.51 | 233.02 | 113.94 | Upgrade
|
| Other Operating Activities | 249.97 | 93.83 | 407.02 | 150.81 | 19.43 | Upgrade
|
| Change in Accounts Receivable | 203.76 | -201.66 | -185.7 | -61.64 | -51.65 | Upgrade
|
| Change in Inventory | -301.09 | -395.17 | -147.71 | -50.78 | -83.77 | Upgrade
|
| Change in Accounts Payable | 104.27 | 110.65 | -50.14 | 147.57 | 23.3 | Upgrade
|
| Change in Unearned Revenue | 72.05 | -32.16 | -86.83 | -89.24 | -89.24 | Upgrade
|
| Change in Other Net Operating Assets | -0.94 | -198.26 | -10.71 | 14.62 | 103.2 | Upgrade
|
| Operating Cash Flow | -205.48 | -205.79 | -500.99 | -325.35 | -443.17 | Upgrade
|
| Capital Expenditures | -101.97 | -136.96 | -76.11 | -30.82 | -38.49 | Upgrade
|
| Sale (Purchase) of Intangibles | -7.88 | -10 | 90.76 | -1.43 | 99.69 | Upgrade
|
| Investment in Securities | 179.49 | 902.52 | -180.46 | -1,015 | 434.21 | Upgrade
|
| Investing Cash Flow | 69.64 | 755.56 | -165.8 | -1,047 | 495.41 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 1,127 | - | Upgrade
|
| Long-Term Debt Repaid | -162.59 | -0.07 | - | -823.23 | - | Upgrade
|
| Net Debt Issued (Repaid) | -162.59 | -0.07 | - | 304.17 | - | Upgrade
|
| Issuance of Common Stock | 38.7 | 79.53 | 51.25 | 30.04 | 569.33 | Upgrade
|
| Repurchase of Common Stock | -25.01 | - | - | - | -7.77 | Upgrade
|
| Other Financing Activities | -19.45 | 45.35 | 73.76 | -101.7 | - | Upgrade
|
| Financing Cash Flow | -168.34 | 124.81 | 125 | 232.51 | 561.57 | Upgrade
|
| Net Cash Flow | -304.18 | 674.58 | -541.79 | -1,140 | 613.81 | Upgrade
|
| Free Cash Flow | -307.45 | -342.74 | -577.1 | -356.17 | -481.66 | Upgrade
|
| Free Cash Flow Margin | -13.99% | -18.02% | -46.41% | -38.17% | -68.62% | Upgrade
|
| Free Cash Flow Per Share | -3.07 | -3.18 | -6.25 | -4.07 | -5.93 | Upgrade
|
| Cash Interest Paid | 14.91 | 15.86 | 15.92 | 44.42 | 55.95 | Upgrade
|
| Cash Income Tax Paid | 37.63 | 22.59 | 15.08 | 1.7 | 0.58 | Upgrade
|
| Levered Free Cash Flow | 95.92 | -432.21 | -330.11 | -54.65 | -8.7 | Upgrade
|
| Unlevered Free Cash Flow | 119.75 | -420.71 | -316.36 | -21.37 | 31.01 | Upgrade
|
| Change in Working Capital | 78.04 | -716.61 | -481.09 | -39.47 | -98.17 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.